AGFG1 Antikörper (AA 276-380) (Cy3)
Kurzübersicht für AGFG1 Antikörper (AA 276-380) (Cy3) (ABIN881810)
Target
Alle AGFG1 (HRB) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 276-380
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AGFG1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- AGFG1 (HRB) (HIV-1 Rev Binding Protein (HRB))
-
Andere Bezeichnung
- AGFG1
-
Hintergrund
-
Synonyms: HIV 1 Rev binding protein, RAB, Rev/Rex activation domain-binding protein, RIP, AGFG1, AGFG1_HUMAN, Arf-GAP domain and FG repeats-containing protein 1, ArfGAP with FG repeats 1, HIV-1 Rev-binding protein, HRB, Nucleoporin like protein RIP, Nucleoporin-like protein RIP, Rev interacting protein, Rev-interacting protein.
Background: Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication.
Target
-